{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-021978","form_type":"8-K","ticker":"ACXP","cik":"0001736243","company_name":"Acurx Pharmaceuticals, Inc.","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.663257+00:00","generated_at":"2026-05-25T01:49:43.732662+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Acurx Pharmaceuticals raises $1.1M in registered direct offering and private warrants","bullets":["Aggregate gross proceeds of ~$1.1M from 2.15M common shares and 595K pre-funded warrants at $0.40/share.","Private placement includes Series F warrants for up to 8.235M shares at $0.40, exercisable upon stockholder approval.","H.C. Wainwright exclusive placement agent; 7% cash fee plus warrants for 164,700 shares at $0.50.","Net proceeds to be used for working capital and general corporate purposes.","Offering expected to close on or about March 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-021978","json":"https://secwatch.observer/filing/0001104659-25-021978.json","markdown":"https://secwatch.observer/filing/0001104659-25-021978.md","text":"https://secwatch.observer/filing/0001104659-25-021978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925021978/0001104659-25-021978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925021978/tm258692d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T01:49:43.732662+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}